Are RNAi and miRNA therapeutics truly dead?

被引：41
|
作者：
Conde, Joao [1 ,2 ]
Artzi, Natalie [1 ,3 ]
机构：
[1] MIT, Harvard Mit Div Hlth Sci & Technol, Inst Med Engn & Sci, Cambridge, MA 02139 USA
[2] Queen Mary Univ London, Sch Engn & Mat Sci, London, England
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol, Boston, MA 02115 USA
来源：
TRENDS IN BIOTECHNOLOGY | 2015年 / 33卷 / 03期
关键词：
RNAi; delivery vehicle; pharmaceutical companies; nanotechnology; biomaterials; SIRNA DELIVERY; DESIGN; POTENT;
D O I：
10.1016/j.tibtech.2014.12.005
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Only a few years ago pharmaceutical companies were excited about the potential of RNA interference (RNAi). Now, financial volatility and subsequent dissolutions of in-house facilities by pharmaceutical companies have had media channels pronouncing that RNAi therapeutics are dead. However, advances in nanomedicine may now help the vast potential of RNAi therapeutics to be fulfilled.
引用
收藏
页码：141 / 144
页数：4
相关论文
共 50 条
  • [31] Pharmacological potential of RNAi - Focus on miRNA
    Pfeifer, Alexander
    Lehmann, Holger
    PHARMACOLOGY & THERAPEUTICS, 2010, 126 (03) : 217 - 227
  • [32] RNAI THERAPEUTICS SCREENING FOR GENE THERAPY
    Zhu, York
    French, Peter
    Peng, Wei
    Lu, Yi-Xiang
    Li, Tie-Jun
    Sun, Yun-Cheng
    Tang, Xiao-Jun
    Shan, Li
    Chen, Jay
    Wang, Jinkang
    JOURNAL OF GENE MEDICINE, 2011, 13 (7-8): : 417 - 418
  • [33] An Eye-opener for RNAi Therapeutics
    Berkhout, Ben
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2008, 107 (10) : 749 - 750
  • [34] Emerging Approaches for Enabling RNAi Therapeutics
    Mallick, Argha M.
    Tripathi, Archana
    Mishra, Sukumar
    Mukherjee, Asmita
    Dutta, Chiranjit
    Chatterjee, Ananya
    Sinha Roy, Rituparna
    CHEMISTRY-AN ASIAN JOURNAL, 2022, 17 (16)
  • [35] RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies
    Malhotra, Meenakshi
    Toulouse, Andre
    Godinho, Bruno M. D. C.
    Mc Carthy, David John
    Cryan, John F.
    O'Driscoll, Caitriona M.
    MOLECULAR BIOSYSTEMS, 2015, 11 (10) : 2635 - 2657
  • [36] RNAi and miRNA in Viral Infections and Cancers
    Mollaie, Hamid Reza
    Monavari, Seyed Hamid Reza
    Arabzadeh, Seyed Ali Mohammad
    Shamsi-Shahrabadi, Mahmoud
    Fazlalipour, Mehdi
    Afshar, Reza Malekpour
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (12) : 7045 - 7056
  • [37] miRNA Shuttles Improve Therapeutic RNAi
    Boudreau, Ryan L.
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2006, 13 : S37 - S37
  • [38] Hot paper in RNAI - Birth of an miRNA
    Wagh, Manasee
    SCIENTIST, 2007, 21 (05): : 71 - 71
  • [39] Promises and challenges of miRNA therapeutics
    Long, Jianyin
    Danesh, Farhad R.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2022, 323 (06) : F673 - F674
  • [40] It is Time to Revisit miRNA Therapeutics
    Corey, David R.
    NUCLEIC ACID THERAPEUTICS, 2025, 35 (01) : 1 - 5
12345